Show notes
What good is innovation if patients can't get it? In this episode of PAC & Forth, we sit down with Sam Chung, Senior Vice President of Government Relations and External Affairs at California Life Sciences, which represents 1,300 organizations across the state's biopharma, biotech, medical device, and research community. Sam unpacks: How prior authorization is driving real harm, with one in three patients facing adverse outcomes.Why vertical integration of PBMs, insurers, and pharmacies is...

